ALEXA CHUPICK: Open Payments
NPI 1366060923 · DELRAY BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$991 in 59 payments from 15 companies in 2025. Trend: 2023 $1,092 · 2024 $1,155 · 2025 $991
Food & beverage: $991
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 15 | $245 |
| E.R. Squibb & Sons, L.L.C. | 19 | $210 |
| Novartis Pharmaceuticals Corporation | 5 | $90 |
| Amgen Inc. | 4 | $80 |
| ANI Pharmaceuticals, Inc. | 2 | $59 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| Janssen Biotech, Inc. | 2 | $46 |
| PFIZER INC. | 2 | $39 |
| Radius Health, Inc. | 1 | $29 |
| GlaxoSmithKline, LLC. | 1 | $28 |
Products named: Bimzelx, ORENCIA, COSENTYX, PURIFIED CORTROPHIN GEL, SAPHNELO, TREMFYA, KRYSTEXXA, XELJANZ.
Industry payments across FL — which companies pay providers there.
